Estrogen and endocrine-disrupting chemicals (EDCs) that are associated with several health outcomes have been found in hair products. We evaluated the proportion, frequency, duration, and content of hair products in a racially/ethnically diverse population. We recruited n = 301 African-American, African-Caribbean, Hispanic, and white women from the New York metropolitan area. We collected data on hair oil, lotion, leave-in conditioner, root stimulator, perm, and other product use. Estrogen and EDC information was collected from commonly used hair products’ labels (used by >3% of population). African-American and African-Caribbean women were more likely to use all types of hair products compared to white women (P < 0.0001). Among hair product users, frequency varied significantly by race/ethnicity, but not duration. More African-Americans (49.4%) and African-Caribbeans (26.4%) used products containing placenta or EDCs compared to whites (7.7%). African-American and African-Caribbean women were more likely to be exposed to hormonally-active chemicals in hair products.
Personal care products African-American Endocrine disruptors
This is a preview of subscription content, log in to check access.
Andrea Deierlein, Ghasi Phillips, Gonzalo Maldanado, Denise Esserman, Lina Titievsky, Teresa Janevic, Kellee White, Danella Hafeman, Sharon Schwartz, study and focus group participants. This project was funded by a pilot grant from The Jean Sindab African-American Breast Cancer Project.
Tiwary CM. Premature sexual development in children following the use of estrogen- or placenta-containing hair products. Clin Pediatr (Phila). 1998;37(12):733–9.CrossRefGoogle Scholar
Donovan M, et al. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses. 2007;68(4):756–66.PubMedCrossRefGoogle Scholar
Li ST, et al. Hormone-containing hair product use in prepubertal children. Arch Pediatr Adolesc Med. 2002;156(1):85–6.PubMedGoogle Scholar
Tiwary CM, Ward JA. Use of hair products containing hormone or placenta by US military personnel. J Pediatr Endocrinol Metab. 2003;16(7):1025–32.PubMedCrossRefGoogle Scholar
Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas. 2001;38(1):103–13. (discussion 113–116).PubMedCrossRefGoogle Scholar
Stahlhut RW, et al. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115(6):876–82.PubMedCrossRefGoogle Scholar
Tiwary CM. A survey of use of hormone/placenta-containing hair preparations by parents and/or children attending pediatric clinics. Mil Med. 1997;162(4):252–6.PubMedGoogle Scholar
Gomez E, et al. Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. J Toxicol Environ Health A. 2005;68(4):239–51.PubMedCrossRefGoogle Scholar
Hatch EE, et al. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002. Environ Health. 2008;7:27.PubMedCrossRefGoogle Scholar